Literature DB >> 12763484

Haemostatic changes in pregnancy.

Katarina A Bremme1.   

Abstract

Normal pregnancy is accompanied by changes in the coagulation and fibrinolytic systems. These include increases in a number of clotting factors (I, II, VII, VIII, IX and XII), a decrease in protein S levels and inhibition of fibrinolysis. As gestation progresses, there is also a significant fall in the activity of activated protein C, an important anticoagulant. While these physiological changes may be important for minimizing intrapartum blood loss, they entail an increased risk of thromboembolism during pregnancy and the post-partum period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763484     DOI: 10.1016/s1521-6926(03)00021-5

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  81 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

2.  Changes in blood parameters and the expression of coagulation-related genes in lactating Sprague-Dawley rats.

Authors:  Yoshinaka Urasoko; Xi Jun He; Takano Masao; Yuichi Kinoshita; Hiroshi Edamoto; Kazuhisa Hatayama; Yuzo Asano; Kazutoshi Tamura; Masahiro Mochizuki
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

3.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

4.  The course of acquired von Willebrand syndrome during pregnancy among patients with essential thrombocytosis.

Authors:  Amihai Rottenstreich; Geffen Kleinstern; Hagai Amsalem; Yosef Kalish
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 5.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

6.  High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Jawed Fareed; Debra Hoppensteadt; Nandor Gabor Than; Bo Hyun Yoon; Sam Edwin; Zhong Dong; Jimmy Espinoza; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-01

Review 7.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

8.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

9.  Natural coagulation inhibitors and active protein c resistance in preeclampsia.

Authors:  Cengiz Demir; Imdat Dilek
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

10.  Venous thromboembolism in pregnancy.

Authors:  Marcelo P Villa-Forte Gomes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.